Onconetix Share Price
NASDAQ: ONCO | Micro Cap | HealthcareOnconetix Stock Performance
Onconetix Share Price Today
As of 22 November 2026, Onconetix, Inc.'s share price is $2.86. The stock opened at $2.93, compared to its previous close of $3.15. During today's trading session, Onconetix, Inc.'s share price traded between $2.93 and $2.93, with an average price of $2.93. Over the past 52 weeks, the stock has recorded a high of $7.72 and a low of $0.09. In terms of performance, Onconetix, Inc.'s share price has risen by 137.34% over the last six months and is up 4.57% on a year-on-year basis.
Onconetix Share Price Chart
Onconetix Quarterly Profit & Loss
All figures in USD
Onconetix Annual Profit & Loss
All figures in USD
Onconetix Balance Sheet
All figures in USD Million
Onconetix Cash Flow
All figures in USD Million
Corporate Actions
About Onconetix
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Onconetix Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.51 | $2.93 | +436.63% |
Oct 2026 | $0.77 | $0.55 | -29.73% |
Sep 2026 | $0.72 | $0.78 | +21.79% |
Aug 2026 | $0.80 | $0.64 | -15.61% |
Jul 2026 | $1.04 | $0.76 | -34.83% |
Jun 2026 | $1.18 | $1.16 | -3.73% |
May 2026 | $0.66 | $1.21 | +75.40% |
Apr 2026 | $1.46 | $0.69 | -54.05% |
Mar 2026 | $0.65 | $1.50 | +126.52% |
Feb 2026 | $1.39 | $0.66 | -55.41% |
Jan 2026 | $1.69 | $1.48 | -7.50% |
Dec 2025 | $2.70 | $1.60 | -41.50% |